DeepLook Medical is highlighting results from a study at Oxford University Hospitals NHS Foundation Trust that used the company's DL Precise color visual enhancement software.
The findings, presented at the British Society of Breast Radiology (BSBR) 2026 meeting, showed that use of the software increased radiologists’ sensitivity for detecting breast cancer by 5.2% without a meaningful increase in false positives.
In the retrospective study, led by Dr. Sarim Ather and Dr. Aya Deabes, four consultant breast radiologists reviewed 400 consecutive diagnostic mammography cases with and without DL Precise. In dense and mixed-density breasts, 35% of cancers initially scored as indeterminate (M3) were reclassified as suspicious (M4 or higher) with the software. Specificity was essentially unchanged, at 77.7% without the software and 77.2% with it, and the software added a median of 13 seconds of reading time per case.
